1. Home
  2. OCUP vs IPW Comparison

OCUP vs IPW Comparison

Compare OCUP & IPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUP
  • IPW
  • Stock Information
  • Founded
  • OCUP 2018
  • IPW 2018
  • Country
  • OCUP United States
  • IPW United States
  • Employees
  • OCUP N/A
  • IPW N/A
  • Industry
  • OCUP Biotechnology: Pharmaceutical Preparations
  • IPW Catalog/Specialty Distribution
  • Sector
  • OCUP Health Care
  • IPW Consumer Discretionary
  • Exchange
  • OCUP Nasdaq
  • IPW Nasdaq
  • Market Cap
  • OCUP 53.1M
  • IPW 48.0M
  • IPO Year
  • OCUP N/A
  • IPW 2021
  • Fundamental
  • Price
  • OCUP $1.22
  • IPW $1.50
  • Analyst Decision
  • OCUP Strong Buy
  • IPW Strong Buy
  • Analyst Count
  • OCUP 3
  • IPW 1
  • Target Price
  • OCUP $18.67
  • IPW $2.75
  • AVG Volume (30 Days)
  • OCUP 90.4K
  • IPW 638.3K
  • Earning Date
  • OCUP 11-11-2024
  • IPW 11-12-2024
  • Dividend Yield
  • OCUP N/A
  • IPW N/A
  • EPS Growth
  • OCUP N/A
  • IPW N/A
  • EPS
  • OCUP N/A
  • IPW N/A
  • Revenue
  • OCUP $16,449,000.00
  • IPW $86,071,485.00
  • Revenue This Year
  • OCUP N/A
  • IPW $8.31
  • Revenue Next Year
  • OCUP $258.69
  • IPW $77.15
  • P/E Ratio
  • OCUP N/A
  • IPW N/A
  • Revenue Growth
  • OCUP N/A
  • IPW N/A
  • 52 Week Low
  • OCUP $1.15
  • IPW $0.40
  • 52 Week High
  • OCUP $3.40
  • IPW $3.65
  • Technical
  • Relative Strength Index (RSI)
  • OCUP 44.79
  • IPW 48.47
  • Support Level
  • OCUP $1.24
  • IPW $1.55
  • Resistance Level
  • OCUP $1.34
  • IPW $2.36
  • Average True Range (ATR)
  • OCUP 0.08
  • IPW 0.24
  • MACD
  • OCUP 0.00
  • IPW -0.02
  • Stochastic Oscillator
  • OCUP 12.00
  • IPW 22.00

About OCUP Ocuphire Pharma Inc.

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting the front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema.

About IPW iPower Inc.

iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.

Share on Social Networks: